Released Oct 22, 2026, during market hours
10-Q filed Nov 13, 2026, 44 days after period end · 0001096906-26-001742
In brief, consolidated total 3Q 2026 revenues were $1,191 (12.1%) lower than in 3Q 2025, and 9M 2026 revenues were $3,602 (12.1%) lower than in 9M 2025.
The release| Metric | Q3 2026 | Q3 2025 | Q3 2024 | Q3 2023 |
|---|---|---|---|---|
| Revenue | $8.62M | $9.81M | $10.01M | $12.51M |
| Net Income | $2.79M | $2.63M | $3.56M |
Utah Medical Products Inc · CIK 706698 · Engraved from SEC EDGAR
| $3.94M |
| EPS Diluted | $0.88 | $0.82 | $1.03 | $1.08 |
|---|
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Total consolidated 3Q 2026 UTMD worldwide sales were $8,621 compared to $9,812 in 3Q 2025, and 9M 2026 sales were $25,873 compared to $29,474 in 9M 2025.¶2¶3
Sales to PendoTECH and the former China BPM kit distributor were zero in 3Q 2026, after combined sales of $491 in 3Q 2025 and $2,419 in 9M 2025.¶1¶4
Worldwide Filshie Clip System sales were $805 (32.7%) lower in 3Q 2026 than in 3Q 2025, while Orion Medical Supplies added $619 in 3Q 2026 sales.¶5
Net income was $2,787 in 3Q 2026 compared to $2,631 in 3Q 2025, and diluted EPS was $0.876 compared to $0.820.¶6¶7
Cash and investments were $85.2 million at September 30, 2026, compared to $85.8 million at December 31, 2025, after $3.0 million in dividends and $5.0 million for the Orion acquisition.¶8